Our two locations in Germany

The principal office of the company is Ruhpolding in Upper Bavaria, where the headquarters are registered.

The R&D of the company is based in Potsdam, Brandenburg. Here are based the research laboratories, which are the main developing and production location for the new insulin to be used in the planned clinical study, in order to achieve the company goal “better quality of life for diabetic people”.